North America Spinal Cord Stimulation Devices Market Size

North America Spinal Cord Stimulation Devices Market Size Forecast 2025

North America Spinal Cord Stimulation Devices Market By Product (Rechargeable and Non-Rechargeable) By Application (Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications)

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : October-2019 | Number of Pages : 55 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the North America Spinal Cord Stimulation Devices Market

Market Report Description

The North America Spinal Cord Stimulation Devices Market would witness market growth of 7.54% CAGR during the forecast period (2019-2025). North America dominated the regional market in 2018 and is anticipated to sustain its dominance in the future as well. This trend is associated with increased cases of chronic pain, CRPS, and failed back syndrome. Furthermore, the widespread awareness about spinal cord stimulation therapy, the existence of well-established healthcare settings, and skilled doctors’ presence in these settings are expected to boost the market growth. It is also anticipated that the rapid acceptance of technologically advanced products will stimulate market growth.

Although stimulation of the spinal cord is the most established part of the therapeutic family known as neuromodulation, its applications are still evolving. The International Neuromodulation Society defines neuromodulation as a therapeutic contact with the central, peripheral, or autonomic treatment interaction with the nervous system through targeted electrical stimulation or pharmacological delivery from implanted equipment.

Click Here For Free Insights

Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.

Scope of the Spinal Cord Stimulation Devices Market Analysis

Market Segmentation:

By Product

  • Rechargeable
  • Non-Rechargeable

By Application

  • Complex Regional Pain Syndrome
  • Unsuccessful Disk Surgery
  • Failed Back Syndrome
  • Degenerative Disk Disease
  • Other Applications

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories (St. Jude Medical, Inc.)
  • Neurosigma, Inc.
  • Nevro Corporation
  • Synapse BioMedical, Inc.
  • Integer Holdings Corporation
  • Stimwave Technologies, Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Spinal Cord Stimulation Devices Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities